Royal Bank Of Canada reiterated their outperform rating on shares of Concordia Healthcare Corp (TSE:CXR) in a research report sent to investors on Tuesday morning. Royal Bank Of Canada currently has a C$18.50 price objective on the stock.

Other analysts have also recently issued reports about the stock. TD Securities boosted their price objective on shares of Concordia Healthcare Corp from C$7.00 to C$14.00 and gave the stock a hold rating in a research note on Monday, September 19th. Goldman Sachs Group Inc. set a C$34.00 price objective on shares of Concordia Healthcare Corp in a research note on Friday, July 22nd. Finally, CIBC cut shares of Concordia Healthcare Corp from a sector perform rating to an underperform rating in a research note on Monday, August 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of Hold and an average target price of C$27.38.

Concordia Healthcare Corp (TSE:CXR) opened at 5.72 on Tuesday. The stock has a 50 day moving average of $8.42 and a 200-day moving average of $24.53. Concordia Healthcare Corp has a 52 week low of $5.64 and a 52 week high of $58.75. The stock’s market cap is $291.82 million.

About Concordia Healthcare Corp

Receive News & Stock Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related stocks with our FREE daily email newsletter.